Tositumomab
From Proteopedia
(Difference between revisions)
Line 69: | Line 69: | ||
! Rituximab | ! Rituximab | ||
! Ibritumomab | ! Ibritumomab | ||
- | |} | ||
|} | |} |
Revision as of 06:38, 6 December 2010
Pharmacokinetics
Anti-CD20 Monoclonal Antibody Pharmacokinetics | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Parameter | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
Tmax (hr) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
Cmax (ng/ml) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
Bioavailability (%) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
Protein Binding (%) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
T1/2 (hr) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
AUC (ng/ml/hr) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
Clearance (L/h) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
IC50 (nM) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
Dosage (mg) | Tositumomab | Ofatumumab | Rituximab | Ibritumomab | |||||||
Metabolism | Tositumomab | Ofatumumab | Rituximab | Ibritumomab |